NIH's Secret Powwow: Meeting Announced, Details MIA
Published Date: 12/19/2025
Notice
Summary
The NIH Clinical Center Research Hospital Board is holding a hybrid meeting on January 30, 2026, open to the public both in-person and online. This meeting affects researchers, healthcare professionals, and the public interested in NIH updates and hospital priorities. Attendees can expect leadership announcements and updates on recent activities, with security and access details provided for those visiting in person.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
NIH Clinical Center hybrid public meeting
You can attend the NIH Clinical Center Research Hospital Board meeting in person at Building 31, 9000 Rockville Pike, Bethesda, MD, or watch it online via the NIH Videocast at https://videocast.nih.gov/ on January 30, 2026 from 9:00 a.m. to 1:00 p.m.
Advance notice for special assistance
If you need special assistance or reasonable accommodations to attend the meeting, you should notify the Contact Person listed in the notice in advance of the January 30, 2026 meeting.
Campus security and ID requirements
If you attend the meeting on campus, NIH will inspect visitor vehicles and require one form of identification (for example, a government-issued photo ID, driver's license, or passport) and that you state the purpose of your visit, per NIH security procedures.
Opportunity to file written comments
Any interested person may file written comments for the committee by sending a statement (including name, address, telephone number, and when applicable, professional affiliation) to the Contact Person(s) listed in the notice.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-23318, Proposed Extension of Information Collection Request Submitted for Public Comment; Comment Request for Form 1099-OID
The IRS wants to keep collecting info using Form 1099-OID, which reports certain financial details. They’re asking the public to share thoughts by February 17, 2026, to help make the process easier and less time-consuming. This affects anyone who deals with this form, but no big changes or costs are expected—just a smooth extension of current rules.
Next: 2025-23320, National Institute on Aging; Amended Notice of Meeting
The National Institute on Aging changed its big advisory meeting from two days to just one day, now happening virtually on January 27, 2026. This update affects anyone interested in aging research and public health planning. The meeting will be partly closed to the public, so mark your calendars and stay tuned for important updates!